AI drug discovery player 1910 Genetics debuts with $26m war chest

There’s a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing.

The Cambridge, Massachusetts-based startup claims it is the only biotech launched so far that will use AI to design both small-molecule drugs and protein therapeutics, coupled with automated biological testing to speed up drug development and reduce costs.